Cargando…
Human Milk Oligosaccharide 2′-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model
BACKGROUND: Human milk is uniquely suited to provide optimal nutrition and immune protection to infants. Human milk oligosaccharides are structural complex and diverse consisting of short chain and long chain oligosaccharides typically present in a 9:1 ratio. 2′-Fucosyllactose (2′FL) is one of the m...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854647/ https://www.ncbi.nlm.nih.gov/pubmed/29593719 http://dx.doi.org/10.3389/fimmu.2018.00452 |
_version_ | 1783306944620003328 |
---|---|
author | Xiao, Ling Leusink-Muis, Thea Kettelarij, Nienke van Ark, Ingrid Blijenberg, Bernadet Hesen, Nienke A. Stahl, Bernd Overbeek, Saskia A. Garssen, Johan Folkerts, Gert van’t Land, Belinda |
author_facet | Xiao, Ling Leusink-Muis, Thea Kettelarij, Nienke van Ark, Ingrid Blijenberg, Bernadet Hesen, Nienke A. Stahl, Bernd Overbeek, Saskia A. Garssen, Johan Folkerts, Gert van’t Land, Belinda |
author_sort | Xiao, Ling |
collection | PubMed |
description | BACKGROUND: Human milk is uniquely suited to provide optimal nutrition and immune protection to infants. Human milk oligosaccharides are structural complex and diverse consisting of short chain and long chain oligosaccharides typically present in a 9:1 ratio. 2′-Fucosyllactose (2′FL) is one of the most prominent short chain oligosaccharides and is associated with anti-infective capacity of human milk. AIM: To determine the effect of 2′FL on vaccination responsiveness (both innate and adaptive) in a murine influenza vaccination model and elucidate mechanisms involved. METHODS: A dose range of 0.25–5% (w/w) dietary 2′FL was provided to 6-week-old female C57Bl/6JOlaHsd mice 2 weeks prior primary and booster vaccination until the end of the experiment. Intradermal (i.d.) challenge was performed to measure the vaccine-specific delayed-type hypersensitivity (DTH). Antigen-specific antibody levels in serum as well as immune cell populations within several organs were evaluated using ELISA and flow cytometry, respectively. In an ex vivo restimulation assay, spleen cells were cocultured with influenza-loaded bone marrow-derived dendritic cells (BMDCs) to study the effects of 2′FL on vaccine-specific CD4+ and CD8+ T-cell proliferation and cytokine secretions. Furthermore, the direct immune regulatory effects of 2′FL were confirmed using in vitro BMDCs T-cell cocultures. RESULTS: Dietary 2′FL significantly (p < 0.05) enhanced vaccine specific DTH responses accompanied by increased serum levels of vaccine-specific immunoglobulin (Ig) G1 and IgG2a in a dose-dependent manner. Consistently, increased activation marker (CD27) expression on splenic B-cells was detected in mice receiving 2′FL as compared to control mice. Moreover, proliferation of vaccine-specific CD4+ and CD8+ T-cells, as well as interferon-γ production after ex vivo restimulation were significantly increased in spleen cells of mice receiving 2′FL as compared to control mice, which were in line with changes detected within dendritic cell populations. Finally, we confirmed a direct effect of 2′FL on the maturation status and antigen presenting capacity of BMDCs. CONCLUSION: Dietary intervention with 2′FL improves both humoral and cellular immune responses to vaccination in mice, which might be attributed in part to the direct effects of 2′FL on immune cell differentiation. |
format | Online Article Text |
id | pubmed-5854647 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58546472018-03-28 Human Milk Oligosaccharide 2′-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model Xiao, Ling Leusink-Muis, Thea Kettelarij, Nienke van Ark, Ingrid Blijenberg, Bernadet Hesen, Nienke A. Stahl, Bernd Overbeek, Saskia A. Garssen, Johan Folkerts, Gert van’t Land, Belinda Front Immunol Immunology BACKGROUND: Human milk is uniquely suited to provide optimal nutrition and immune protection to infants. Human milk oligosaccharides are structural complex and diverse consisting of short chain and long chain oligosaccharides typically present in a 9:1 ratio. 2′-Fucosyllactose (2′FL) is one of the most prominent short chain oligosaccharides and is associated with anti-infective capacity of human milk. AIM: To determine the effect of 2′FL on vaccination responsiveness (both innate and adaptive) in a murine influenza vaccination model and elucidate mechanisms involved. METHODS: A dose range of 0.25–5% (w/w) dietary 2′FL was provided to 6-week-old female C57Bl/6JOlaHsd mice 2 weeks prior primary and booster vaccination until the end of the experiment. Intradermal (i.d.) challenge was performed to measure the vaccine-specific delayed-type hypersensitivity (DTH). Antigen-specific antibody levels in serum as well as immune cell populations within several organs were evaluated using ELISA and flow cytometry, respectively. In an ex vivo restimulation assay, spleen cells were cocultured with influenza-loaded bone marrow-derived dendritic cells (BMDCs) to study the effects of 2′FL on vaccine-specific CD4+ and CD8+ T-cell proliferation and cytokine secretions. Furthermore, the direct immune regulatory effects of 2′FL were confirmed using in vitro BMDCs T-cell cocultures. RESULTS: Dietary 2′FL significantly (p < 0.05) enhanced vaccine specific DTH responses accompanied by increased serum levels of vaccine-specific immunoglobulin (Ig) G1 and IgG2a in a dose-dependent manner. Consistently, increased activation marker (CD27) expression on splenic B-cells was detected in mice receiving 2′FL as compared to control mice. Moreover, proliferation of vaccine-specific CD4+ and CD8+ T-cells, as well as interferon-γ production after ex vivo restimulation were significantly increased in spleen cells of mice receiving 2′FL as compared to control mice, which were in line with changes detected within dendritic cell populations. Finally, we confirmed a direct effect of 2′FL on the maturation status and antigen presenting capacity of BMDCs. CONCLUSION: Dietary intervention with 2′FL improves both humoral and cellular immune responses to vaccination in mice, which might be attributed in part to the direct effects of 2′FL on immune cell differentiation. Frontiers Media S.A. 2018-03-09 /pmc/articles/PMC5854647/ /pubmed/29593719 http://dx.doi.org/10.3389/fimmu.2018.00452 Text en Copyright © 2018 Xiao, Leusink-Muis, Kettelarij, van Ark, Blijenberg, Hesen, Stahl, Overbeek, Garssen, Folkerts and van’t Land. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Xiao, Ling Leusink-Muis, Thea Kettelarij, Nienke van Ark, Ingrid Blijenberg, Bernadet Hesen, Nienke A. Stahl, Bernd Overbeek, Saskia A. Garssen, Johan Folkerts, Gert van’t Land, Belinda Human Milk Oligosaccharide 2′-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model |
title | Human Milk Oligosaccharide 2′-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model |
title_full | Human Milk Oligosaccharide 2′-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model |
title_fullStr | Human Milk Oligosaccharide 2′-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model |
title_full_unstemmed | Human Milk Oligosaccharide 2′-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model |
title_short | Human Milk Oligosaccharide 2′-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model |
title_sort | human milk oligosaccharide 2′-fucosyllactose improves innate and adaptive immunity in an influenza-specific murine vaccination model |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854647/ https://www.ncbi.nlm.nih.gov/pubmed/29593719 http://dx.doi.org/10.3389/fimmu.2018.00452 |
work_keys_str_mv | AT xiaoling humanmilkoligosaccharide2fucosyllactoseimprovesinnateandadaptiveimmunityinaninfluenzaspecificmurinevaccinationmodel AT leusinkmuisthea humanmilkoligosaccharide2fucosyllactoseimprovesinnateandadaptiveimmunityinaninfluenzaspecificmurinevaccinationmodel AT kettelarijnienke humanmilkoligosaccharide2fucosyllactoseimprovesinnateandadaptiveimmunityinaninfluenzaspecificmurinevaccinationmodel AT vanarkingrid humanmilkoligosaccharide2fucosyllactoseimprovesinnateandadaptiveimmunityinaninfluenzaspecificmurinevaccinationmodel AT blijenbergbernadet humanmilkoligosaccharide2fucosyllactoseimprovesinnateandadaptiveimmunityinaninfluenzaspecificmurinevaccinationmodel AT hesennienkea humanmilkoligosaccharide2fucosyllactoseimprovesinnateandadaptiveimmunityinaninfluenzaspecificmurinevaccinationmodel AT stahlbernd humanmilkoligosaccharide2fucosyllactoseimprovesinnateandadaptiveimmunityinaninfluenzaspecificmurinevaccinationmodel AT overbeeksaskiaa humanmilkoligosaccharide2fucosyllactoseimprovesinnateandadaptiveimmunityinaninfluenzaspecificmurinevaccinationmodel AT garssenjohan humanmilkoligosaccharide2fucosyllactoseimprovesinnateandadaptiveimmunityinaninfluenzaspecificmurinevaccinationmodel AT folkertsgert humanmilkoligosaccharide2fucosyllactoseimprovesinnateandadaptiveimmunityinaninfluenzaspecificmurinevaccinationmodel AT vantlandbelinda humanmilkoligosaccharide2fucosyllactoseimprovesinnateandadaptiveimmunityinaninfluenzaspecificmurinevaccinationmodel |